RxDoctor Payments Data

James Russell, MD

Otolaryngology · Little Rock, ARNPI 1801282231

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.6% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 25.4% of the total.

$2,638in general payments, 2019–2025

Across 86 payments — averaging $30.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$671
  • Stryker$655
  • GSK$468
  • Sanofi$282
  • Optinose US, Inc.$187
  • Acclarent, Inc$122
  • plus $253 from 9 others

What the payments were for

  • Travel & lodging$893%
  • Food & beverage$2,54997%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,638 in reported general payments places this provider in the 80th percentile of 72 otolaryngology providers in Arkansas.

See all otolaryngology providers in Arkansas

Medicare billing

Part B allowed, 2024
$464,337
Medicare patients
1,536
Services billed
7,967

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide253$12,729
Epinephrine34$4,944
Advair HfaFluticasone Propion/Salmeterol17$4,937
Azelastine Hcl102$3,586
Fluticasone Propionate98$1,386
Cefdinir73$1,301
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,299
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip14$1,083
Omeprazole104$735
Ofloxacin37$684
Fluocinolone Acetonide Oil19$560
Gabapentin56$493
Mupirocin61$478
Prednisone289$366
Famotidine23$356

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →